Oct 14, 2026 08:06AM
Aug 12, 2026 04:14PM
May 18, 2026 10:27AM
May 12, 2026 04:46PM
May 12, 2026 04:45PM
May 8, 2026 04:29AM
May 7, 2026 08:05AM Atara Biotherapeutics receives FDA guidance on tabelecleucel resubmission
Mar 12, 2026 08:05AM
Mar 3, 2026 08:06AM
Feb 23, 2026 08:00AM
Jan 13, 2026 06:19AM
Jan 12, 2026 08:04AM
Jan 2, 2026 04:06PM
Dec 19, 2025 04:03AM Atara Biotherapeutics (ATRA) PT Raised to $25 at Canaccord Genuity
Nov 21, 2025 06:34AM
Nov 3, 2025 09:04AM
Aug 18, 2025 06:25AM
Aug 11, 2025 04:53PM
Jul 24, 2025 08:00AM
Jul 14, 2025 08:01AM
May 15, 2025 05:09PM ATARA Biotherapeutics (ATRA) Tops Q1 EPS by 350c
May 15, 2025 08:31AM
Jan 28, 2025 06:41AM
Jan 27, 2025 04:38PM
Jan 21, 2025 03:45PM
Jan 21, 2025 07:32AM
Jan 17, 2025 06:31AM
Jan 16, 2025 08:56AM ATARA Biotherapeutics (ATRA) to Resume Trading at 9 am after receiving CRL from FDA
Jan 16, 2025 08:35AM
Dec 20, 2024 06:42AM
Nov 13, 2024 09:10AM
Sep 3, 2024 04:16PM
Aug 16, 2024 09:03AM
Aug 12, 2024 05:40PM
Jul 17, 2024 09:01AM ATARA Biotherapeutics (ATRA) Announces U.S. FDA Acceptance and Priority Review of BLA for Tabelecleucel for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease
Jun 17, 2024 08:00AM

471,208 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All